Skip to main content
Top
Published in: Journal of General Internal Medicine 8/2018

01-08-2018 | Concise Research Reports

Patients’ Perception of Newly Initiated Oral Anticoagulant Treatment for Atrial Fibrillation: an Observational Study

Authors: Josiane Larochelle, M.Sc, Caroline Brais, M.Sc, Lucie Blais, Ph.D, Sylvie Perreault, Ph.D, Paul Farand, M. Sc, FRFCP, Geneviève Letemplier, MD, FRFCP, Marie-France Beauchesne, Pharm.D

Published in: Journal of General Internal Medicine | Issue 8/2018

Login to get access

Excerpt

Patient’s satisfaction with oral anticoagulants (OAC) for the treatment of atrial fibrillation has been reported,14 but not in new users of warfarin or direct oral anticoagulants (DOACs). The main objective of this study was to describe patient’s expectations and satisfaction with oral anticoagulant treatment. …
Literature
1.
go back to reference Fareau S, Baumstarck K, Farcet A, et al. Evaluation de la qualité de vie des patients âgés en fibrillation atriale sous anticoagulants au long cours: antivitamine K versus anticoagulants oraux directs. Ger Psychol Neurophsychiatr Vieil 2015 ;13 :45–54. Fareau S, Baumstarck K, Farcet A, et al. Evaluation de la qualité de vie des patients âgés en fibrillation atriale sous anticoagulants au long cours: antivitamine K versus anticoagulants oraux directs. Ger Psychol Neurophsychiatr Vieil 2015 ;13 :45–54.
2.
go back to reference Fumagalli S, Cardini F, Roberts AT, et al. Psychological effects of treatment with new oral anticoagulants in elderly patients with atrial fibrillation: a preliminary report. Aging Clin Exp Res 2015; 27:99–102.CrossRef Fumagalli S, Cardini F, Roberts AT, et al. Psychological effects of treatment with new oral anticoagulants in elderly patients with atrial fibrillation: a preliminary report. Aging Clin Exp Res 2015; 27:99–102.CrossRef
4.
go back to reference MasDalmau G, Arderiu ES, Enfedaque Montes MB, Solà I, Pequeño Saco S, Coello PA. Patients’ and physicians’ perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review. BMC Fam Pract 2017; 18:1–11.CrossRef MasDalmau G, Arderiu ES, Enfedaque Montes MB, Solà I, Pequeño Saco S, Coello PA. Patients’ and physicians’ perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review. BMC Fam Pract 2017; 18:1–11.CrossRef
5.
go back to reference Prins MH, Marrel A, Carita P, et al. Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the ‘Perception of Anticoagulant Treatment Questionnaire’ (PACT-Q). Health Qual Life Outcomes. 2009;7:9.CrossRef Prins MH, Marrel A, Carita P, et al. Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the ‘Perception of Anticoagulant Treatment Questionnaire’ (PACT-Q). Health Qual Life Outcomes. 2009;7:9.CrossRef
6.
go back to reference Prins MH, Guillemin I, Gilet H, et al. Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q). Health Qual Life outcomes. 2009;7:30.CrossRef Prins MH, Guillemin I, Gilet H, et al. Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q). Health Qual Life outcomes. 2009;7:30.CrossRef
Metadata
Title
Patients’ Perception of Newly Initiated Oral Anticoagulant Treatment for Atrial Fibrillation: an Observational Study
Authors
Josiane Larochelle, M.Sc
Caroline Brais, M.Sc
Lucie Blais, Ph.D
Sylvie Perreault, Ph.D
Paul Farand, M. Sc, FRFCP
Geneviève Letemplier, MD, FRFCP
Marie-France Beauchesne, Pharm.D
Publication date
01-08-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 8/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4457-z

Other articles of this Issue 8/2018

Journal of General Internal Medicine 8/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.